Thursday, 25 February 2010

Sertralina Combix




Sertralina Combix may be available in the countries listed below.


Ingredient matches for Sertralina Combix



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Combix in the following countries:


  • Spain

International Drug Name Search

Wednesday, 24 February 2010

Furox




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Furox



Furazolidone

Furazolidone is reported as an ingredient of Furox in the following countries:


  • United States

International Drug Name Search

Monday, 22 February 2010

Hydrotricine




Hydrotricine may be available in the countries listed below.


Ingredient matches for Hydrotricine



Tyrothricin

Tyrothricin is reported as an ingredient of Hydrotricine in the following countries:


  • Italy

  • Portugal

International Drug Name Search

Saturday, 20 February 2010

Mubonet




Mubonet may be available in the countries listed below.


Ingredient matches for Mubonet



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Mubonet in the following countries:


  • Mexico

International Drug Name Search

Thursday, 18 February 2010

Quilonorm retard




Quilonorm retard may be available in the countries listed below.


Ingredient matches for Quilonorm retard



Lithium

Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Quilonorm retard in the following countries:


  • Austria

  • Switzerland

International Drug Name Search

Saturday, 13 February 2010

Clindahexal




Clindahexal may be available in the countries listed below.


Ingredient matches for Clindahexal



Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Clindahexal in the following countries:


  • Germany

  • South Africa

International Drug Name Search

Thursday, 11 February 2010

Betapace AF


Pronunciation: SOE-ta-lol
Generic Name: Sotalol
Brand Name: Betapace AF

Because Betapace AF may sometimes cause an abnormal or irregular heartbeat, patients who begin taking or restart Betapace AF should be observed in a hospital or similar setting in which heart and kidney function monitoring may be performed for at least 3 days after starting Betapace AF. Close monitoring of your heart or kidney function may also be needed if your dose is changed. Do not change from one brand or generic version of Betapace AF to another without consulting your doctor or pharmacist. Betapace AF is labeled specifically for atrial fibrillation or atrial flutter.





Betapace AF is used for:

Maintaining a normal heartbeat rhythm in patients who have atrial fibrillation or atrial flutter (a type of abnormal heartbeat rhythm).


Betapace AF is an antiarrhythmic medicine. It works by helping the heart beat regularly for a longer period of time.


Do NOT use Betapace AF if:


  • you are allergic to any ingredient in Betapace AF

  • you have certain types of irregular heartbeat (eg, long QT syndrome, prolonged QT interval), shock caused by serious heart problems, uncontrolled heart failure, low blood potassium or magnesium levels, certain lung or breathing problems (eg, asthma, bronchitis, emphysema), severe kidney problems, or you are on dialysis

  • you have a very slow heartbeat or certain types of irregular heartbeat (sick sinus syndrome, second- or third-degree heart block) and you do not have a permanent pacemaker

  • you are taking certain antiarrhythmics (eg, amiodarone, disopyramide, dofetilide, procainamide, quinidine), bepridil, cisapride, mibefradil, nilotinib, tetrabenazine, a theophylline (eg, aminophylline), a tricyclic antidepressant (eg, amitriptyline), or vardenafil

Contact your doctor or health care provider right away if any of these apply to you.



Before using Betapace AF:


Some medical conditions may interact with Betapace AF. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have breathing or lung problems (eg, chronic obstructive pulmonary disorder [COPD], asthma); an overactive thyroid; kidney problems; diabetes; blood flow problems; a tumor on your adrenal gland; loss of appetite; increased thirst; or severe or persistent diarrhea, sweating, or vomiting

  • if you have a history of other heart problems (eg, heart failure, slow or irregular heartbeat, a recent heart attack), blood electrolyte problems (eg, low blood potassium or magnesium levels), problems with the acid or base levels in your body, or episodes of low blood sugar

  • if you are scheduled for surgery

Some MEDICINES MAY INTERACT with Betapace AF. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Indomethacin because it may decrease Betapace AF's effectiveness

  • Calcium channel blockers (eg, diltiazem, verapamil), clonidine, digoxin, diuretics (eg, furosemide, hydrochlorothiazide), guanethidine, mibefradil, or reserpine because the risk of side effects, such as low blood pressure or heart problems, may be increased

  • Antiarrhythmics (eg, dronedarone, propafenone), arsenic, astemizole, bepridil , chloroquine, cisapride, dolasetron, domperidone, droperidol, fingolimod, fluconazole, halofantrine, haloperidol, iloperidone, ketanserin, macrolides and ketolides (eg, erythromycin), maprotiline, mefloquine, methadone, nilotinib, oseltamivir, paliperidone, pentamidine, phenothiazines (eg, chlorpromazine, thioridazine), pimozide, quinolones (eg, ciprofloxacin), romidepsin, saquinavir, terfenadine, tetrabenazine, tricyclic antidepressants (eg, amitriptyline), tyrosine kinase inhibitors (eg, dasatinib), vardenafil, or ziprasidone because the risk of abnormal heart rhythms may be increased

  • Epinephrine, insulin, lidocaine, meglitinide antidiabetics (eg, nateglinide), or quinazolines (eg, prazosin) because the risk of their side effects may be increased by Betapace AF

  • Beta-agonists (eg, albuterol) or theophyllines (eg, aminophylline) because their effectiveness may be decreased by Betapace AF

This may not be a complete list of all interactions that may occur. Ask your health care provider if Betapace AF may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Betapace AF:


Use Betapace AF as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Betapace AF. Talk to your pharmacist if you have questions about this information.

  • Take Betapace AF by mouth with or without food. Try to take it the same way (either with food or without food) each time you take your dose. Check with your doctor or pharmacist if you have questions about taking Betapace AF with food.

  • Do not take an antacid that has aluminum or magnesium in it within 2 hours before or after you take Betapace AF.

  • Betapace AF works best if it is taken at the same time each day. Taking Betapace AF at the same time each day will also help you remember to take it.

  • Continue to use Betapace AF even if you feel well. Do not miss any doses.

  • If you miss a dose of Betapace AF, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Betapace AF.



Important safety information:


  • Betapace AF may cause dizziness or lightheadedness. These effects may be worse if you take it with alcohol or certain medicines. Use Betapace AF with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Betapace AF may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Do NOT take more than the recommended dose or change your dose without checking with your doctor.

  • Tell your doctor or dentist that you take Betapace AF before you receive any medical or dental care, emergency care, or surgery.

  • Do not suddenly stop taking Betapace AF. Sharp chest pain, irregular heartbeat, and, sometimes, heart attack may occur if you suddenly stop Betapace AF. The risk may be greater if you have certain types of heart disease. Heart disease is common and you may not know you have it. Your doctor should slowly lower your dose over several weeks if you need to stop taking it. Limit physical activity while you are lowering your dose. If new or worsened chest pain or other heart problems occur, contact your doctor right away. You may need to start taking Betapace AF again.

  • Diabetes patients - Betapace AF may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • Diabetes patients - Betapace AF may hide signs of low blood sugar, such as rapid heartbeat. Be sure to watch for other signs of low blood sugar. Low blood sugar may make you anxious, sweaty, weak, dizzy, drowsy, or faint. It may also make your vision change; give you a headache, chills, or tremors; or make you more hungry. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • If you have a history of any severe allergic reaction, talk with your doctor. You may be at risk of an even more severe allergic reaction if you come into contact with the substance that caused your allergy. Some medicines used to treat severe allergies may also not work as well while you are taking Betapace AF.

  • Betapace AF may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Betapace AF.

  • Lab tests, including kidney and heart function, and blood pressure monitoring, may be performed while you take Betapace AF. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Betapace AF while you are pregnant. Betapace AF is found in breast milk. Do not breast-feed while taking Betapace AF.


Possible side effects of Betapace AF:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; headache; lightheadedness; mild diarrhea, nausea, or stomach pain; tiredness; trouble sleeping.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormally fast, slow, or irregular heartbeat; changes in vision; chest pain; decreased appetite; excessive thirst; fainting; numbness of an arm or leg; severe or persistent nausea, vomiting, or diarrhea; severe or persistent tiredness; severe stomach pain; shortness of breath; sudden leg pain; sudden, severe headache, vomiting, or dizziness; unusual sweating.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Betapace AF side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include difficulty breathing; dizziness; fainting; fatigue; severe weakness; slow heartbeat.


Proper storage of Betapace AF:

Store Betapace AF at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Betapace AF out of the reach of children and away from pets.


General information:


  • If you have any questions about Betapace AF, please talk with your doctor, pharmacist, or other health care provider.

  • Betapace AF is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Betapace AF. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Betapace AF resources


  • Betapace AF Side Effects (in more detail)
  • Betapace AF Dosage
  • Betapace AF Use in Pregnancy & Breastfeeding
  • Drug Images
  • Betapace AF Drug Interactions
  • Betapace AF Support Group
  • 1 Review for Betapace AF - Add your own review/rating


  • Betapace AF Prescribing Information (FDA)

  • Betapace AF Advanced Consumer (Micromedex) - Includes Dosage Information

  • Betapace AF Concise Consumer Information (Cerner Multum)

  • Sotalol Prescribing Information (FDA)

  • Betapace Concise Consumer Information (Cerner Multum)

  • Betapace Prescribing Information (FDA)

  • Sorine Prescribing Information (FDA)

  • Sotalol Hydrochloride Monograph (AHFS DI)



Compare Betapace AF with other medications


  • Atrial Fibrillation
  • Atrial Flutter

Wednesday, 10 February 2010

Normoptic




Normoptic may be available in the countries listed below.


Ingredient matches for Normoptic



Timolol

Timolol is reported as an ingredient of Normoptic in the following countries:


  • Tunisia

International Drug Name Search

Oxytetracycline HCL




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxytetracycline HCL



Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxytetracycline HCL in the following countries:


  • Netherlands

  • Taiwan

  • United States

International Drug Name Search

Saturday, 6 February 2010

Toxemia of pregnancy Medications


Definition of Toxemia of pregnancy: Eclampsia is the occurrence of seizures (not attributed to another cause) during pregnancy (usually after the 20th week).

Topics under Toxemia of pregnancy

  • HELLP Syndrome (0 drugs)

Learn more about Toxemia of pregnancy





Drug List:

Thursday, 4 February 2010

Fexofenadinhydrochlorid Orifarm




Fexofenadinhydrochlorid Orifarm may be available in the countries listed below.


Ingredient matches for Fexofenadinhydrochlorid Orifarm



Fexofenadine

Fexofenadine hydrochloride (a derivative of Fexofenadine) is reported as an ingredient of Fexofenadinhydrochlorid Orifarm in the following countries:


  • Germany

International Drug Name Search

Wednesday, 3 February 2010

Minoxile




Minoxile may be available in the countries listed below.


Ingredient matches for Minoxile



Minoxidil

Minoxidil is reported as an ingredient of Minoxile in the following countries:


  • Argentina

International Drug Name Search

Tuesday, 2 February 2010

Lipomed




Lipomed may be available in the countries listed below.


Ingredient matches for Lipomed



Simvastatin

Simvastatin is reported as an ingredient of Lipomed in the following countries:


  • Myanmar

International Drug Name Search

Monday, 1 February 2010

Sizopin




Sizopin may be available in the countries listed below.


Ingredient matches for Sizopin



Clozapine

Clozapine is reported as an ingredient of Sizopin in the following countries:


  • Bangladesh

  • India

  • Sri Lanka

International Drug Name Search